Ocular Safety Assessment Services

Ocular Safety Assessment Services

• Glaucoma
• Choroidal Neovascularization (CNV)
• Age-Related Macular Degeneration (AMD)

• Keratoconjunctivitis Sicca (KCS)
• Allergic Conjunctivitis
• Anterior Uveitis
• Infectious Keratitis

• Neuroprotection
• Corneal Wound Healing
• Diabetic Macular Edema

Ocular safety assessment services are integral to the pharmaceutical industry's pursuit of innovative ocular therapeutics. With over two decades of expertise, our company stands as a leading provider in ocular safety assessment services. Our team boasts extensive experience in ocular safety assessment, including small molecules, biologics, cell therapy, gene therapy, implants, and transplants. This breadth of expertise allows us to tailor our services to the unique requirements of each project, assessments.

Our Capabilities

Our company offers a diverse array of ocular safety assessment services, underpinned by a commitment to excellence and scientific rigor. Our capabilities encompass:

Ocular Disease Models

Central to our ocular safety assessment services are validated disease models that accurately simulate various ocular conditions. These models include:

By employing these disease models, we facilitate the identification of potential therapeutic targets and the evaluation of novel treatment modalities.

Comprehensive Clinical Evaluations

At our company, we offer comprehensive clinical evaluations to assess the ocular health and function of experimental subjects. Our experienced team of researchers conducts thorough examinations, including tonometry, pachymetry, specular photomicroscopy, fundus photography, fluorescein angiography, and more, to provide a comprehensive understanding of ocular anatomy and physiology. These evaluations serve as a crucial foundation for evaluating the safety and efficacy of ocular therapeutics, guiding decision-making in the development process.

Quantitative Inflammation Evaluation

Our company employs state-of-the-art techniques, such as laser flare meter analysis, to quantitatively evaluate inflammation in ocular tissues. By accurately quantifying inflammation levels, we provide valuable insights into the inflammatory response elicited by experimental treatments, enabling our clients to assess the safety profile of their drug candidates and refine their development strategies accordingly.

Dose Routes

Our company offers a comprehensive range of dose administration routes tailored to the specific needs of ocular drug development. These routes include:

Each route offers unique advantages in terms of drug delivery efficiency and tissue targeting, allowing for precise and effective administration of therapeutic agents.

Our Imaging Technologies

Our ocular study capabilities are further enhanced by the utilization of advanced imaging technologies, including:

These non-invasive imaging modalities allow for high-resolution visualization of ocular structures and facilitate the assessment of treatment effects on tissue morphology and function. By incorporating advanced imaging technologies into our studies, we enhance our ability to elucidate the mechanisms of action of ocular therapeutics and optimize treatment strategies.

Through our proficiency in disease model utilization, comprehensive clinical evaluations, quantitative inflammation evaluation, and advanced imaging technologies, we empower our clients to advance the development of innovative ocular therapeutics with confidence and precision. Contact us to learn more about how we can support your scientific endeavors and help you achieve your goals.

Trust Us for Your Safety Assessment Needs.

Our company offers a comprehensive range of ocular safety assessment services to support a wide range of research and development efforts in the pharmaceutical, biotechnology, materials science and chemical industries.

CONTACT US

Please kindly note that our products and services are for research use only.